TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5614.13M
Enterprise Value 3533.93M
Trailing P/E N/A
Forward P/E 1-5.45
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4,040.32
Price/Book (mrq)31.03
Enterprise Value/Revenue 33,512.69
Enterprise Value/EBITDA 6-3.19

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-110,205.26%

Management Effectiveness

Return on Assets (ttm)-87.78%
Return on Equity (ttm)-319.87%

Income Statement

Revenue (ttm)152k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)152k
EBITDA -167.42M
Net Income Avi to Common (ttm)-167.11M
Diluted EPS (ttm)-2.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)92.47M
Total Cash Per Share (mrq)1.08
Total Debt (mrq)37.86M
Total Debt/Equity (mrq)196.65
Current Ratio (mrq)1.72
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-134.23M
Levered Free Cash Flow (ttm)-71.45M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.63
52-Week Change 3-46.26%
S&P500 52-Week Change 34.92%
52 Week High 316.00
52 Week Low 33.32
50-Day Moving Average 37.73
200-Day Moving Average 35.92

Share Statistics

Avg Vol (3 month) 32.39M
Avg Vol (10 day) 31.62M
Shares Outstanding 585.3M
Float 56.88M
% Held by Insiders 111.16%
% Held by Institutions 168.87%
Shares Short (Apr 30, 2019) 415.26M
Short Ratio (Apr 30, 2019) 47.57
Short % of Float (Apr 30, 2019) 423.46%
Short % of Shares Outstanding (Apr 30, 2019) 417.07%
Shares Short (prior month Mar 29, 2019) 417.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 256/1
Last Split Date 3Apr 30, 2012